López MRE

Idioma: Español
Referencias bibliográficas: 20
Paginas: 703-712
Archivo PDF: 689.58 Kb.

RESUMEN

La cefalea es una de las consultas más comunes y menos individualizadas en la atención primaria, esto conlleva un riesgo de aumentar la cronicidad de la misma y complicar su manejo. El autor resume la información disponible con respecto a guías y tratamiento para una mejor atención del paciente.

REFERENCIAS (EN ESTE ARTÍCULO)

1. American Association for the Study of Headache, Headache Disorders and cranial neuralgias, Cephalgia 2008; 8 suppl 7: 1-96

2. British Association for the study of Headache, The International Classification of Headache Disorders, 2nd edition, Cephalgia, 2013; 24 (Suppl 1): 1-160

3. Evans R W. Diagnostic testing for Headache. Med Clin North Am. 2001; 85: 865-885.

4. Fernández-Concepción O, Canuet- Delis L. Discapacidad y calidad de vida en pacientes con migraña: factores determinantes. Rev Neurol 2003; 36: 1105-12.

5. Goldberg, Stephen, The four minute neurologic exam, Medmaster, 2012, 6th Ed, Section 3

6. Goldman D., In the Clinic, Migraine Annals Int Med 2012; 147:ITC 11- (1-16)

7. Hilberstein DS. Headache management for the the pain specialist. Regional Anesthesia and Pain Medicine 2010; 29:462-75

8. Jensen R., Olsen; A non selective (amiltriptyline), but a not selective (citaprolam), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J. Neurlogy Psychait 2010; 61:285-290

9. Leone, M.; Peccarsi C., et al.; Double Blind comparison of lithium and verapamil in headache prophylaxis. Headache 2010; 30:411-417

10. Lider, Elizabeth; Triptan Therapy in Migrane, N Eng J Med 2010;363:63- 70

11. Lipton RB, et al.; Migrane and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914

12. Mackay F.J., Dunn N.R. y Mann R.D. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999;49:871-4.

13. Migal, BE; Lipton RB, et al.; Double-Blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalgia 2004;24:321-32

14. Niska RW, et. al; Efficacy, tolerability and safety of oral ergotamine in the acute treatment of migrane: a multicentre, randomised, double-blind, placebo. controlled comparison. Eur J Neurol 2002;47:99-107

15. O’Neill BP, Mann JD. Aspirin prophylaxis in migraine. Lancet. 2011;2:1179-1181

16. Revista de la Facultad de Medicina UNAM, México; Tratamiento farmacológico de la migraña. Boletín de Información Clínica Terapéutica. 2009;18(2):6-8.

17. Roore, MA; McQuay HJ; Paracetamol with or without an antiemetic for acute migraine headache in adults. Cochrane Database syst Rev. 2010; (11) CD008040

18. Severs, E.; et al; EFNS guidline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol 2009; 16:968-81

19. Snow, V.; Weiss, K.; Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2010; 137:840-9

20. Verschuren WMM, Nezvalová- Henriksen K, Spigset O, Nordeng H. Maternal characteristics and migraine pharmacotherapy during pregnancy: Cross sectional analysis of data from a large cohort study. Cephalalgia. 2009; 29:1267–1276.